ロード中...
TRAIL in cancer therapy: present and future challenges
Since its identification in 1995, TRAIL (TNF-Related Apoptosis Inducing Ligand) has sparked growing interest in oncology due to its reported ability to selectively trigger cancer cell death. Contrary to other members of the TNF superfamily, TRAIL administration in vivo is harmless. The relative abse...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Informa Healthcare
2007
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2976473/ https://ncbi.nlm.nih.gov/pubmed/17907960 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14728222.11.10.1299 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|